scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.14.12.1906 |
P698 | PubMed publication ID | 7981178 |
P2093 | author name string | P Alaupovic | |
H N Hodis | |||
W J Mack | |||
D H Blankenhorn | |||
D M Kramsch | |||
L Cashin-Hemphill | |||
L LaBree | |||
C N Corder | |||
C Knight-Gibson | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1906-1913 | |
P577 | publication date | 1994-12-01 | |
P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
P1476 | title | Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS) | |
P478 | volume | 14 |
Q34552595 | An update on carotid ultrasound measurement of intima-media thickness |
Q88167231 | Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D |
Q33781706 | Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort |
Q47764147 | Biologic markers as predictors of cardiovascular disease |
Q54171141 | Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments. |
Q34552563 | Documenting regression of atherosclerosis: practical approaches in drug development |
Q73589935 | Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels |
Q40338516 | Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency |
Q38293501 | Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function |
Q51565712 | Effects of fibric acid derivatives and metformin on postprandial lipemia. |
Q37457665 | Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele |
Q73110411 | The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial |
Q48033046 | Use of apolipoprotein parameters and endpoints in drug development and approval processes |
Search more.